Martin Sheringham Linsell

This inventor holds 82 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Antibacterial Compounds (CPC class C07D471-04). Top assignees: Theravance, Inc., Achaogen, Inc., Kodiak Sciences Inc.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Sheringham Linsell. Retrieved from https://idiyas.com/inventor/martin-sheringham-linsell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 82 (Patent Applications = 12)

% Patents Active = 79.3

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 3.6

ph-index = 17

Forward Citations = 757(Granted Patents)

Forward Citations (Not Self Cited) = 463(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Foster City, CA (US) (2003)
San Francisco, CA (US) (2005 - 2011)
South San Francisco, CA (US) (2022)
San Mateo, CA (US) (2000 - 2023)

Company Filing History:

Advanced Medicine, Inc.

patents

6. 2 out of 40

Axys Pharmaceuticals, Inc.

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Antibacterial Agents

IL-17 Modulators

Glycopeptide Derivatives

Benzenecarboxamides

Aminoglycoside Analogs

Zwitterionic Polymers

Factor VIII Conjugates

Cephalosporin Compounds

Pharmaceutical Compositions

Cross-Linked Antibiotics

Glycopeptide Phosphonates

82 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421212 - Substituted benzenecarboxamides as IL-17A modulators (2025-09-23),

2. 12234225 - IL-17 ligands and uses thereof (2025-02-25),

3. 12214044 - Factor VIII zwitterionic polymer conjugates (2025-02-04),

4. 11590235 - Factor VIII zwitterionic polymer conjugates (2023-02-28),

5. 11447468 - IL-17 ligands and uses thereof (2022-09-20),

6. 11274094 - Substituted benzenecarboxamides as IL-17A modulators (2022-03-15),

7. 11117915 - Antibacterial aminoglycoside analogs (2021-09-14),

8. 11071771 - Butyrylcholinesterase zwitterionic polymer conjugates (2021-07-27),

9. 10702608 - Factor VIII zwitterionic polymer conjugates (2020-07-07),

10. RE47741 - Antibacterial aminoglycoside analogs (2019-11-25),

11. 10363290 - Butyrylcholinesterase zwitterionic polymer conjugates (2019-07-30),

12. 9701622 - Antibacterial agents (2017-07-11),

13. 9688711 - Antibacterial aminoglycoside analogs (2017-06-27),

14. 9403758 - Antibacterial agents (2016-08-02),

15. 9266919 - Antibacterial aminoglycoside analogs (2016-02-23),

Title: Martin Sheringham Linsell - Pioneering Inventor from San Mateo

Introduction: Martin Sheringham Linsell is a distinguished inventor based in San Mateo, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Martin Sheringham Linsell holds several recent patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With over two decades of experience in the industry, Martin has led numerous successful projects that have revolutionized the way we approach modern challenges. His commitment to pushing the boundaries of innovation is evident in his extensive patent portfolio.

Collaborations: Throughout his career, Martin has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Martin Sheringham Linsell's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.